Overall, our results show that: (i) the immunohistochemistry expression of TIMP-1 was low compared to the levels of TIMP-2 and -3 in serous ovarian tumors and no significant differences could be observed between different Stages, Grades and Type of tumors compared to control. Here, TIMP2 is linked to ovarian serous tumor.